10 healthcare players aiming beyond health equality to conquer health equity

1. A market research report on 10 Healthcare Players aiming Beyond Health Equality to Conquer Health Equity

2. What would this Report Cover? 1. Health Equity: A Virtuous Cycle 2. Factors Manifesting Health Equity 3. Healthcare Players Aiming Healthcare Equity • Bayer • Gilead • Sanofi • Bristol Myers Squibb • Johnson & Johnson • Merck • Pfizer • AstraZeneca • Takeda • Biogen 2

3. 1. Health Equity: A Virtuous Cycle Pharmaceutical and life sciences companies has unlocked new opportunities, help underserved patients, and build a cycle of trust to drive a virtuous cycle 1. Analyse (High Quality Data) Consider the information and data we have now 1. Analyse 2. Expand (Problem Solving) Consider whose problems we have been solving 4. 2. Health Equity Engage Expand 3. Challenge (Targeted Approaches) Consider why some groups are not receiving the appropriate medicine or therapy at the right time 3. 4. Engage (Better Collaboration) Consider whom else we can collaborate with to fill the identified gaps, & how we can encourage more people to receive needed care Challenge 3

4. 2. Factors Manifesting Health Equity Intricately complicated health disorders can progress, and access disparities, unmet needs, or marginalized communities can all be signs of health inequities Lack of adequate alignment between innovation initiatives and the global burden of disease Unmet Needs Patients who are unable to access or afford needs like wholesome food, suitable treatment, or essential medications Limited Access Health Equity Underserved Communities Determinants of ecological health (including payers and providers) failing to engage groups appropriately for the needs of group members 4

5. 3. Healthcare Players Aiming Healthcare Equity (1/5) Bayer Gilead ▪ Gilead repurposing Ebola drug remdesivir as the first treatment for COVID boosted its overall reputation last year ▪ Bayer’s U.S. business nabbed a perfect score from the Human Rights Campaign Foundation’s Corporate Equality Index ▪ Helps boost the overall ranking from alva for the company, which also has a major focus on food and nutrition and agriculture ▪ Gilead launched Zeroing In: Ending the HIV Epidemic, which gifted $24 million in grants to 116 organizations in 41 countries to tackle the problem on the ground ▪ Bayer also works with the new Women in STEM leadership pilot program across 12 countries that the Pistoia Alliance recently announced ▪ The company wants to hire or promote 200 Black Americans without a four-year degree while also increasing Hispanic representation to 15% of its U.S. workforce and 3.7% of leadership roles and boosting female leadership representation to 39% 5

6. 3. Healthcare Players Aiming Healthcare Equity (2/5) Sanofi Bristol Myers Squibb ▪ The Paris-based company has launched an Employee Resource Group (ERG) framework in which voluntary, employee-led ERGs will focus on five areas—gender, generations, pride, ability and culture and origins ▪ BMS has been at the forefront of the fight to boost diversity by issuing $7.9Mn of health equity grants to 24 U.S. nonprofit organizations aimed at improving access and quality care to medically underserved patients and communities ▪ Sanofi’s DE&I strategy 2025 goals revolve around three key pillars: building representative leadership, creating a work environment where employees can bring their whole selves and engaging with the company’s diverse communities ▪ BMS until 2025 will accelerate five diversity and inclusion and health equity commitments—addressing disparities in healthcare, increasing diversity in clinical trials, expanding supplier diversity, enhancing employee giving to social justice organizations and increasing workforce representation 6

7. 3. Healthcare Players Aiming Healthcare Equity (3/5) Johnson & Johnson Merck ▪ To boost diversity in its clinical trials, Merck is working to build new partnerships with organizations like Black Health Matters, the National Urban League and the Lazarex Cancer Foundation ▪ 2022 was Year 1 of the pharma’s Health for Humanity 2025 plan ▪ The program comes with 20 key goals like boosting women in management, greater diversity in senior teams and improving health equity by developing treatments for underserved HIV and tuberculosis patient communities ▪ The company granted voluntary licenses to several Indian generic manufacturers in an effort to boost the availability of molnupiravir in India and in other low- and middle-income countries ▪ By 2025, the pharma has pledged to have 50% of management positions globally made up of women and also 35% ethnic/racial diversity in U.S. management positions ▪ Also teamed up with Johnson & Johnson to scale up production of J&J's single-shot COVID vaccine to help expand global access 7

8. 3. Healthcare Players Aiming Healthcare Equity (4/5) Pfizer AstraZeneca ▪ Pfizer recently teamed up with trial site network Headlands Research to break ground on several new research sites in diversely populated areas. A new Headlands facility is set to take root in Brownsville, Texas—a city of about 180,000 on the border of Mexico ▪ The Anglo-Swedish Big Pharma's strategy includes two 2025 goals: to reach gender equality in management positions and to launch supplier diversity programs in 10 new countries outside the US ▪ AstraZeneca also participates in the Pistoia Alliance’s new Women in STEM leadership pilot program to enable leadership and mentoring skill development while furthering workplace diversity ▪ Pfizer has joined the Paradigm for Parity coalition, aiming to achieve “full gender parity” by 2030, with a near-term goal of women holding at least 30% of senior roles 8

9. 3. Healthcare Players Aiming Healthcare Equity (4/5) Takeda Biogen ▪ Takeda launched the Center for Health Equity and Patient Affairs (HEPA) as a center of excellence in 2021 and hopes to make it a leader in health equity and patient centricity to “create a more inclusive ecosystem and strengthen trust and reputation with patients and other key external stakeholders around the world ▪ Biogen created a new four-point plan to focus on building a more diverse workforce “at all levels” as well as “building awareness, capability and a sustained urgency to act” ▪ Takeda is also looking to roll out an enterprise-wide Candidate Relationship Management tool connected with an Applicant Tracking System that it hopes will “create inclusive talent communities” 9

10. Who should buy this report? HealthTech Companies MedTech Players Other Lifesciences Companies Pharmaceutical Players Digital Health Entities

11. Topics of Upcoming Reports Will the Expiry of Humira Market Exclusivity and Entry of its Biosimilars Move the Needle in BioPharma Market? Cost of this report: $2,500 Metaverse: Paving the way for Health 4.0 Annual Subscription: $125,000 $60,000 (Includes a total of 50 reports) Patient Engagement- a New Standpoint on Care that is Patient-Centered E-Rx, the Digital Version of Prescription Improvising the Chances of Better Patient Outcomes Integration of Healthcare Systems with Big Data and Data Silos www.insights10.com

12. Methodology & Scope

13. Research Methodology Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources For forecasting, the following parameters are considered: ❑ Market drivers and restraints along with their current and expected impacts ❑ Technological scenario and expected developments ❑ End use industry trends and dynamics ❑ Trends in the consumer behavior ❑ Regulatory scenario and expected developments ❑ Current capacity and expected capacity additions up to 2030 We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time- sensitive, reflecting the most recent value and volume of the market across regions All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs) Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn) ▪ ▪ ▪ ▪ ▪ ▪ ▪ 13 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

14. Analysis Methodology Our Analysis Methodology involves three critical stages: Market Data Analysis & Statistical Model Interpretation & Presentation Data Collection Analysis & Interpretation Market Trends Secondary Research Market Sizing & Analysis Insights Primary Research Presentation & Reporting Data Triangulation & Validation 14 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

15. Data Triangulation & Data Validation Top Down Approach Final Market Size Final Market size break up to rest of segmentation Validation from Primary Interview Arriving at market size of each segment Summarization of revenue generated from companies to arrive at total market size Validation from Primary Interview Revenue generated by products & services offered by companies Final Summary Bottom Up Approach 15 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

16. Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 16 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

17. Time Frame Report Attribute Details Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Base Year for Estimation 2021 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Company Profiles, Competitive Landscape, Regulatory Landscape, Future Opportunities Report Coverage Report Customization (5 working days) with purchase. We will provide you with data that is currently not a part of our scope as a part of customization Customized Report Forecast Period 2022- 2030 Pricing and purchase options Avail customized purchase options to meet your exact research needs

18. What kind of Data is Presented in this Report? This report presents data, which is: Expert-verified Real Comprehensive Easy to read Reliable The data is prepared by a team of highly qualified & experienced research analysts & vetted by our local associates Covers everything you would need to know about the market including market size, competitive analysis & much more You do not have to be a market expert to understand what really is happening on the market and how it works Allowing you to confidently make smarter business and strategic decisions The report is prepared using a proven methodology and insightful research www.insights10.com

19. About

20. Lifesciences Market Research Reports you can trust A large database of over 30,000 syndicated market research reports in pharmaceuticals and healthcare sector at global, regional as well as country level. We also provide customized research reports tailor made to suit your needs www.insights10.com

21. Get Insights to take informed Business Decisions Insights10 is a healthcare focused market research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for businesses www.insights10.com

22. Market Research Reports across various domains of healthcare Pharmaceuticals (Diseases & Drugs) Digital Health Medical Devices Healthcare Services OTC & Clinical Trials Nutraceuticals

23. 1 Full-Time Engagement 6 Market Research Reports Customized Reports 2 7 Conference Coverage Our 8 3 Primary Research Competitive Intelligence Services 4 Strategic Research Projects 9 Regulatory Compliance 10 5 Database Services Report Subscription Services

24. Our Research Process 01 02 03 04 05 Identification of Data Market Dynamics Collection of Data Collaboration of Data Verification & Analysis www.insights10.com

25. Statistical Databases Company Websites/Annual Reports Data Sources Trade Publications We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. Online Databases Published Research Reports Whitepapers Press Releases of Key Market Players www.insights10.com

26. Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences. Our team has conducted market research across 62+ global markets in America, Europe, Middle East, Africa and Asia Pacific regions Research Projects Done

27. Project Leadership Team Dr. Purav Gandhi Founder & CEO Mukesh Nayak Head - Marketing Ritu Baliya Engagement Manager Dhruv Joshi Consultant Purav is a physician and an entrepreneur with 12+ years of experience in Healthcare & Life Sciences industry spanning across strategy, market access, health informatics and RWE, Digital Healthcare, analytics and data science. Purav studied medicine from Gujarat University and also completed his MBA from IIM-Kozhikode. Purav started his career with Deloitte working on strategy consulting engagements and also co- founded ConvergeHealth by Deloitte. Mukesh is an engineering graduate with an MBA in Marketing. He is a seasoned healthcare market research & marketing professional with a progressive experience of over 20 years in Life Sciences, Pharma and Medical Device sectors . With an in-depth understanding of primary research, he has conducted hundreds of interviews of various stakeholders in pharma & healthcare & completed several research projects across life sciences industry. Ritu has over 6 years of experience in strategy building, market assessments, market sizing, and RWE for global MNC healthcare & biopharma clients across diff. markets (America, Europe, Africa, APAC and Middle East). Her areas of expertise include: Indentifying emerging trends in life sciences industry, Competitor landscape assessment, Disease opportunity assessments etc. She is a pro in secondary and primary research with a deep domain expertise in healthcare sector. Dhruv Joshi is an engineer and has done Masters in Hospital Administration with over 4 years of experience in the healthcare and life science industry. He has gained proficiency in market research, market assessment, and developing insights from it. He has worked on various consulting projects across different geographies including Asia, Europe, US, MENA. He has been aligned in working for sector reports of various geographies along with market sizing and forecasting.

28. 7 years of experience working with leading organizations in pharma, MedTech and healthcare domain. Some of our recent clients are mentioned below … and many more

29. We would be happy to help. Web: www.insights10.com Email: insights@insights10.com Call: (+91) 931 639 7935 Whatsapp: (+91) 931 639 7935